AndrewNDauberMDMMSc
Pediatric Endocrinology • Washington, DCPediatric Growth Disorder Endocrinology
Chief of Endocrinology, Children's National Medical Center
Dr. Dauber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave
Washington, DC 20010Phone+1 202-476-2121Fax+1 202-476-4095
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Endocrinology, 2008 - 2011- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2004 - 2008
Harvard Medical SchoolClass of 2004
Certifications & Licensure
MD State Medical License 2024 - 2026
DC State Medical License 2018 - 2024
VA State Medical License 2020 - 2024
MA State Medical License 2006 - 2020
OH State Medical License 2014 - 2019- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age Start of enrollment: 2011 Aug 01
- Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency Start of enrollment: 2018 Feb 01
- Vosoritide for Selected Genetic Causes of Short Stature Start of enrollment: 2020 Aug 04
Publications & Presentations
PubMed
- 32 citationsA Successful HSCT in a Girl with Novel LRBA Mutation with Refractory Celiac DiseaseSinan Sari, Figen Dogu, Vivian Hwa, Sule Haskologlu, Andrew Dauber
Journal of Clinical Immunology. 2016-01-01 - 20 citationsHigh-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency.Peter Gergics, Cathy Smith, Hironori Bando, Alexander A. L. Jorge, Denise Rockstroh-Lippold
American Journal of Human Genetics. 2021-08-05 - 61 citationsDominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation.Jürgen Klammt, David Neumann, Evelien F. Gevers, Shayne Andrew, I. David Schwartz
Nature Communications. 2018-05-29
Journal Articles
- Gain-of-Function DNMT3A Mutations Cause Microcephalic Dwarfism and Hypermethylation of Polycomb-Regulated RegionsAndrew Dauber, MD, Nature
- DLK1 Is a Novel Link Between Reproduction and MetabolismAndrew Dauber, MD, The Journal of Clinical Endocrinology and Metabolism
- Insights and Implications of Genome Wide Association Studies of HeightAndrew Dauber, MD, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
Promising Results After Precision Medicine Trial for Growth Hormone ResistanceMay 30th, 2024- Lumos Pharma Reports First Quarter 2023 Financial Results, Provides Clinical UpdatesMay 3rd, 2023
- Children’s National Named to U.S. News & World Report’s Best Children’s Hospitals Honor RollJune 14th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
